{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T16:56:22Z","timestamp":1786294582577,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82001510"],"award-info":[{"award-number":["82001510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171632"],"award-info":[{"award-number":["82171632"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700605"],"award-info":[{"award-number":["2021YFC2700605"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Medicine Plus X - Young Scholars Project of Peking University, the Fundamental Research Funds for the Central Universities","award":["PKU2024LCXQ047"],"award-info":[{"award-number":["PKU2024LCXQ047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The utilization of a double trigger, involving the co-administration of gonadotropin-releasing hormone agonist (GnRH-a) and human chorionic gonadotropin (hCG) for final oocyte maturation, is emerging as a novel approach in gonadotropin-releasing hormone antagonist (GnRH-ant) protocols during controlled ovarian hyperstimulation (COH). This protocol involves administering GnRH-a and hCG 40 and 34 h prior to ovum pick-up (OPU), respectively. This treatment modality has been implemented in patients with low\/poor oocytes yield. This study aimed to determine whether the double trigger could improve the number of top-quality embryos (TQEs) in patients with fewer than three TQEs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The stimulation characteristics of 35 in vitro fertilization (IVF) cycles were analyzed. These cycles were triggered by the combination of hCG and GnRHa (double trigger cycles) and compared to the same patients\u2019 previous IVF attempt, which utilized the hCG trigger (hCG trigger control cycles). The analysis involved cases who were admitted to our reproductive center between January 2018 and December 2022. In the hCG trigger control cycles, all 35 patients had fewer than three TQEs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients who received the double trigger cycles yielded a significantly higher number of 2PN cleavage embryos (3.54\u2009\u00b1\u20093.37 vs. 2.11\u2009\u00b1\u20092.15, <jats:italic>P<\/jats:italic>\u2009=\u20090.025), TQEs ( 2.23\u2009\u00b1\u20092.05 vs. 0.89\u2009\u00b1\u20090.99, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and a simultaneously higher proportion of the number of cleavage stage embryos (53.87%\u2009\u00b1\u200931.38% vs. 39.80%\u2009\u00b1\u200929.60%, <jats:italic>P<\/jats:italic>\u2009=\u20090.043), 2PN cleavage stage embryos (43.89%\u2009\u00b1\u200933.01% vs. 27.22%\u2009\u00b1\u200927.13%, <jats:italic>P<\/jats:italic>\u2009=\u20090.014), and TQEs (27.05%\u2009\u00b1\u200926.26% vs. 14.19%\u2009\u00b1\u200919.76%, <jats:italic>P<\/jats:italic>\u2009=\u20090.019) to the number of oocytes retrieved compared with the hCG trigger control cycles, respectively. The double trigger cycles achieved higher rates of cumulative clinical pregnancy (20.00% vs. 2.86%, <jats:italic>P<\/jats:italic>\u2009=\u20090.031), cumulative persistent pregnancy (14.29% vs. 0%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and cumulative live birth (14.29% vs. 0%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) per stimulation cycle compared with the hCG trigger control cycles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Co-administration of GnRH-agonist and hCG for final oocyte maturation, 40 and 34 h prior to OPU, respectively (double trigger) may be suggested as a valuable new regimen for treating patients with low TQE yield in previous hCG trigger IVF\/intracytoplasmic sperm injection (ICSI) cycles.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-024-01465-6","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:13:50Z","timestamp":1720016030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF\/ICSI cycles"],"prefix":"10.1186","volume":"17","author":[{"given":"Binbin","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"issue":"3","key":"1465_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ijgo.13405","volume":"152","author":"AM Maged","year":"2021","unstructured":"Maged AM, Ragab MA, Shohayeb A, Saber W, Ekladious S, Hussein EA, El-Mazny A, Hany A. Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study. Int J Gynecol Obstet. 2021;152(3):395\u2013400.","journal-title":"Int J Gynecol Obstet"},{"issue":"8","key":"1465_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/humrep\/deac114","volume":"37","author":"C Zhou","year":"2022","unstructured":"Zhou C, Yang X, Wang Y, Xi J, Pan H, Wang M, Zhou Y, Xiao Y. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles. Hum Reprod. 2022;37(8):1795\u2013805.","journal-title":"Hum Reprod"},{"issue":"3","key":"1465_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/oxfordjournals.humrep.a138520","volume":"9","author":"E Shalev","year":"1994","unstructured":"Shalev E, Geslevich Y, Ben-Ami M. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Hum Reprod. 1994;9(3):417\u20139.","journal-title":"Hum Reprod"},{"issue":"3","key":"1465_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.rbmo.2012.11.002","volume":"26","author":"S Kol","year":"2013","unstructured":"Kol S, Humaidan P. GnRH agonist triggering: recent developments. Reprod Biomed Online. 2013;26(3):226\u201330.","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"1465_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.29252\/ijrm.15.7.429","volume":"15","author":"M Eftekhar","year":"2017","unstructured":"Eftekhar M, Mojtahedi MF, Miraj S, Omid M. Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: An RCT. Int J Reprod Biomed. 2017;15(7):429\u201334.","journal-title":"Int J Reprod Biomed"},{"issue":"7","key":"1465_CR6","doi-asserted-by":"publisher","first-page":"e235707","DOI":"10.1371\/journal.pone.0235707","volume":"15","author":"CU Chern","year":"2020","unstructured":"Chern CU, Li JY, Tsui KH, Wang PH, Wen ZH, Lin LT. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: A retrospective cohort study. PLoS ONE. 2020;15(7):e235707.","journal-title":"PLoS ONE"},{"issue":"2","key":"1465_CR7","first-page":"246","volume":"25","author":"CF Oliveira","year":"2021","unstructured":"Oliveira CF, Oliveira C, Fonseca LL, Souza K, Radaelli M. GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles. J Bras Reprod Assist. 2021;25(2):246\u201351.","journal-title":"J Bras Reprod Assist"},{"issue":"6","key":"1465_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/01443615.2019.1674791","volume":"40","author":"A Ben-Haroush","year":"2020","unstructured":"Ben-Haroush A, Sapir O, Salman L, Altman E, Garor R, Margalit T, Shufaro Y, Oron G. Does \u201cDual Trigger\u201d increase oocyte maturation rate? J Obstet Gynaecol. 2020;40(6):860\u20132.","journal-title":"J Obstet Gynaecol"},{"key":"1465_CR9","doi-asserted-by":"publisher","first-page":"683210","DOI":"10.3389\/fmed.2021.683210","volume":"8","author":"F Gao","year":"2021","unstructured":"Gao F, Wang Y, Fu M, Zhang Q, Ren Y, Shen H, Han H. Effect of a \u201cDual Trigger\u201d Using a GnRH Agonist and hCG on the Cumulative Live-Birth Rate for Normal Responders in GnRH-Antagonist Cycles. Front Med-Lausanne. 2021;8:683210.","journal-title":"Front Med-Lausanne"},{"issue":"4","key":"1465_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5653\/cerm.2020.03804","volume":"47","author":"YE Sukur","year":"2020","unstructured":"Sukur YE, Ulubasoglu H, Ilhan FC, Berker B, Sonmezer M, Atabekoglu CS, Aytac R, Ozmen B. Dual trigger in normally-responding assisted reproductive technology patients increases the number of top-quality embryos. Clin Exp Reprod Med. 2020;47(4):300\u20135.","journal-title":"Clin Exp Reprod Med"},{"issue":"5","key":"1465_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/humrep\/des037","volume":"27","author":"R Beck-Fruchter","year":"2012","unstructured":"Beck-Fruchter R, Weiss A, Lavee M, Geslevich Y, Shalev E. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Hum Reprod. 2012;27(5):1357\u201367.","journal-title":"Hum Reprod"},{"key":"1465_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1757-2215-7-77","volume":"7","author":"J Haas","year":"2014","unstructured":"Haas J, Zilberberg E, Dar S, Kedem A, Machtinger R, Orvieto R. Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles\u2013a preliminary report. J Ovarian Res. 2014;7:77.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1465_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/09513590.2014.978850","volume":"31","author":"E Zilberberg","year":"2015","unstructured":"Zilberberg E, Haas J, Dar S, Kedem A, Machtinger R, Orvieto R. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecol Endocrinol. 2015;31(2):145\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"1465_CR14","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/humrep\/dem221","volume":"22","author":"S Ziebe","year":"2007","unstructured":"Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod. 2007;22(9):2404\u201313.","journal-title":"Hum Reprod"},{"issue":"27","key":"1465_CR15","doi-asserted-by":"publisher","first-page":"e16213","DOI":"10.1097\/MD.0000000000016213","volume":"98","author":"J Song","year":"2019","unstructured":"Song J, Sun Z. A borderline form of empty follicle syndrome treated with a double-trigger of gonadotropin-releasing hormone agonist and human chorionic gonadotropin: A case report. Medicine. 2019;98(27):e16213.","journal-title":"Medicine"},{"issue":"7","key":"1465_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09513590.2019.1576621","volume":"35","author":"J Haas","year":"2019","unstructured":"Haas J, Zilberberg E, Nahum R, Mor SA, Hourvitz A, Gat I, Orvieto R. Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study. Gynecol Endocrinol. 2019;35(7):628\u201330.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1465_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.fertnstert.2014.04.028","volume":"102","author":"D Griffin","year":"2014","unstructured":"Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014;102(2):405\u20139.","journal-title":"Fertil Steril"},{"issue":"3","key":"1465_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","volume":"32","author":"L Engmann","year":"2016","unstructured":"Engmann L, Benadiva C, Humaidan P. GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reprod Biomed Online. 2016;32(3):274\u201385.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1465_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/humupd\/dmr008","volume":"17","author":"P Humaidan","year":"2011","unstructured":"Humaidan P, Kol S, Papanikolaou EG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011;17(4):510\u201324.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1465_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/humupd\/dmv059","volume":"22","author":"R Maggi","year":"2016","unstructured":"Maggi R, Cariboni AM, Marelli MM, Moretti RM, Andre V, Marzagalli M, Limonta P. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update. 2016;22(3):358\u201381.","journal-title":"Hum Reprod Update"},{"key":"1465_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2023.08.014","volume":"289","author":"FF He","year":"2023","unstructured":"He FF, Hu W, Yong L, Li YM. Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF\/ICSI: A systematic review and meta-analysis of randomized trials. Eur J Obstet Gyn R B. 2023;289:65\u201373.","journal-title":"Eur J Obstet Gyn R B"},{"issue":"6","key":"1465_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.rbmo.2017.09.002","volume":"35","author":"J Zhang","year":"2017","unstructured":"Zhang J, Wang Y, Mao X, Chen Q, Hong Q, Cai R, Zhang S, Kuang Y. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF\/ICSI cycles. Reprod Biomed Online. 2017;35(6):701\u20137.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"1465_CR23","first-page":"28","volume":"26","author":"S Albeitawi","year":"2022","unstructured":"Albeitawi S, Marar EA, Reshoud FA, Hamadneh J, Hamza R, Alhasan G, Omeish H, Vigano P. Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles. J Bras Reprod Assist. 2022;26(1):28\u201332.","journal-title":"J Bras Reprod Assist"},{"issue":"8","key":"1465_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4103\/njcp.njcp_574_19","volume":"24","author":"AS Gurbuz","year":"2021","unstructured":"Gurbuz AS, Deveer R, Gode F. Evaluation of Dual Trigger with Combination of Gonadotropin-Releasing Hormone Agonist and Human Chorionic Gonadotropin in Improving Oocyte-Follicle Ratio in Normo-Responder Patients. Niger J Clin Pract. 2021;24(8):1159\u201363.","journal-title":"Niger J Clin Pract"},{"issue":"7","key":"1465_CR25","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","volume":"35","author":"J Haas","year":"2020","unstructured":"Haas J, Bassil R, Samara N, Zilberberg E, Mehta C, Orvieto R, Casper RF. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Hum Reprod. 2020;35(7):1648\u201354.","journal-title":"Hum Reprod"},{"key":"1465_CR26","doi-asserted-by":"publisher","first-page":"367505","DOI":"10.1155\/2010\/367505","volume":"2010","author":"T Vutyavanich","year":"2010","unstructured":"Vutyavanich T, Piromlertamorn W, Ellis J. Immature oocytes in \u201capparent empty follicle syndrome\u201d: a case report. Case Rep Med. 2010;2010:367505.","journal-title":"Case Rep Med"},{"issue":"1","key":"1465_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.fertnstert.2009.09.040","volume":"94","author":"DE Reichman","year":"2010","unstructured":"Reichman DE, Hornstein MD, Jackson KV, Racowsky C. Empty follicle syndrome\u2013does repeat administration of hCG really work? Fertil Steril. 2010;94(1):375\u20137.","journal-title":"Fertil Steril"},{"issue":"3","key":"1465_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.fertnstert.2007.08.008","volume":"90","author":"E Snaifer","year":"2008","unstructured":"Snaifer E, Hugues JN, Poncelet C, Sifer C, Pasquier M, Cedrin-Durnerin I. \u201cEmpty follicle syndrome\u201d after human error: pregnancy obtained after repeated oocyte retrieval in a gonadotropin-releasing hormone antagonist cycle. Fertil Steril. 2008;90(3):813\u201350.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01465-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:17:35Z","timestamp":1720016255000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01465-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"20 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking University Third Hospital Reproductive Center (No. 2018SZ-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}